Research-based membrane separation technology using ultrafiltration, nanofiltration, and pervaporation to remove undesirable components from concentrated coconut water. The approach targets high molecular weight compounds responsible for spoilage using hollow fiber membrane modules with optimized fouling mitigation.
This research proposes a sequence of membrane separation processes to remove undesirable components from frozen concentrated coconut water (FC CCW). The primary targets are high molecular weight compounds responsible for spoilage and off-flavors, particularly enzymes such as polyphenol oxidase (PPO) and peroxidase (POD). The technology aims to deliver an economically viable route for producing high-quality concentrated coconut water by leveraging hollow fiber membrane modules and carefully controlled operating conditions to minimize fouling.
Process sequence:
Key technical considerations:
The approach builds on prior work demonstrating successful enzyme removal from fruit juices, including bromelain separation from pineapple extract using appropriately selected molecular weight cut-off membranes.
The research is at an early-to-mid stage of development. Prior studies have validated ultrafiltration for coconut water sterilization using hollow fiber membranes, and dead-end filtration tests with 30 and 100 kDa membranes have shown substantial decreases in PPO and POD activity. The research group has additional experience with nanofiltration for enzyme removal and fouling characterization across multiple systems. Future work will focus on chemical composition analysis, systematic ultrafiltration testing across different membrane cut-offs and operating conditions, fouling mechanism elucidation, and product acceptability evaluation to advance toward commercial viability.
UFMG is a comprehensive public research university in Belo Horizonte, Brazil, known for interdisciplinary research and talent development. Industry engagement is anchored by the Belo Horizonte Technology Park (BH-TEC), co-located with the main campus for company co-location and joint R&D. Integration with the Hospital das Clínicas, managed by the federal Ebserh network, enables clinical research and large-scale validation. Research is backed by competitive funding from Brazilian federal and state agencies, including CNPq, CAPES, FINEP, and FAPEMIG. CTIT, the university’s technology transfer office, manages IP and partnerships, while the Inova incubator accelerates spinouts.